These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 966246)

  • 1. Tyrosylated analogues of somatostatin.
    Rivier JE; Brown MR; Vale WW
    J Med Chem; 1976 Aug; 19(8):1010-3. PubMed ID: 966246
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Somatostatin: analogs with selected biological activities.
    Brown M; Rivier J; Vale W
    Science; 1977 Jun; 196(4297):1467-9. PubMed ID: 867045
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Somatostatin analogs which inhibit glucagon and growth hormone more than insulin release.
    Meyers C; Arimura A; Gordin A; Fernandez-Durango R; Coy DH; Schally AV; Drouin J; Ferland L; Beaulieu M; Labrie F
    Biochem Biophys Res Commun; 1977 Jan; 74(2):630-6. PubMed ID: 836315
    [No Abstract]   [Full Text] [Related]  

  • 4. [Natural peptides and their analogs. XXXV. Synthesis and properties of [Ala5, Orn9]somatostatin].
    Shvachkin IuP; Smirnova AP; Ermak NM; Fedotov VP; Sadovnikova NV
    Bioorg Khim; 1985 Aug; 11(8):1026-36. PubMed ID: 2865960
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of highly potent octapeptide analogs of somatostatin on growth hormone, insulin and glucagon release.
    Karashima T; Cai RZ; Schally AV
    Life Sci; 1987 Aug; 41(8):1011-9. PubMed ID: 2886886
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relative potencies of the somatostatin analogs octreotide, BIM-23014, and RC-160 on the inhibition of hormone release by cultured human endocrine tumor cells and normal rat anterior pituitary cells.
    Hofland LJ; van Koetsveld PM; Waaijers M; Zuyderwijk J; Lamberts SW
    Endocrinology; 1994 Jan; 134(1):301-6. PubMed ID: 7903931
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery of iodinated somatostatin analogues selective for hsst2 and hsst5 with excellent inhibition of growth hormone and prolactin release from rat pituitary cells.
    Moore SB; van der Hoek J; de Capua A; van Koetsveld PM; Hofland LJ; Lamberts SW; Goodman M
    J Med Chem; 2005 Oct; 48(21):6643-52. PubMed ID: 16220980
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pituitary somatostatin receptors. Characterization by binding with a nondegradable peptide analogue.
    Aguilera G; Parker DS
    J Biol Chem; 1982 Feb; 257(3):1134-7. PubMed ID: 6120162
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and biological activity of glycosylated analogs of somatostatin.
    Lavielle S; Ling N; Brazeau P; Benoit R; Wasada T; Harris D; Unger R; Guillemin R
    Biochem Biophys Res Commun; 1979 Nov; 91(2):614-22. PubMed ID: 518658
    [No Abstract]   [Full Text] [Related]  

  • 10. Biological activities of tyrosine-containing somatostatin analogs on inhibition of secretion of thyrotropin and growth hormone.
    Ohashi S; Sawano S; Kokubu T; Gondo M; Sakakibara K
    Endocrinol Jpn; 1976 Oct; 23(5):435-8. PubMed ID: 1009896
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Phe4]somatostatin: a potent, selective inhibitor of growth hormone release.
    Meyers CA; Coy DH; Murphy WA; Redding TW; Arimura A; Schally AV
    Proc Natl Acad Sci U S A; 1980 Jan; 77(1):577-9. PubMed ID: 6987657
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Three-dimensional quantitative structure-activity relationships of somatostatin analogues. 1. Comparative molecular field analysis of growth hormone release-inhibiting potencies.
    Hocart SJ; Reddy V; Murphy WA; Coy DH
    J Med Chem; 1995 May; 38(11):1974-89. PubMed ID: 7783129
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biological activity of somatostatin and somatostatin analogs on inhibtion of arginine-induced insulin and glucagon release in the rat.
    Brown M; Rivier J; Vale W
    Endocrinology; 1976 Feb; 98(2):336-43. PubMed ID: 813991
    [TBL] [Abstract][Full Text] [Related]  

  • 14. D-Trp8-somatostatin: an analog of somatostatin more potent than the native molecule.
    Rivier J; Brown M; Vale W
    Biochem Biophys Res Commun; 1975 Jul; 65(2):746-51. PubMed ID: 1096897
    [No Abstract]   [Full Text] [Related]  

  • 15. Highly active position eight analogues of somatostatin and separation of peptide diastereomers by partition chromatography.
    Meyers CA; Coy DH; Huang WY; Schally AV; Redding TW
    Biochemistry; 1978 Jun; 17(12):2326-31. PubMed ID: 678512
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pituitary somatostatin receptors: dissociation at the pituitary level of receptor affinity and biological activity for selective somatostatin analogs.
    Reubi JC; Perrin M; Rivier J; Vale W
    Regul Pept; 1982 Aug; 4(3):141-6. PubMed ID: 6127756
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-selective inhibition of basal glucagon release by [D-Cys14]-analogues of somatostatin in the rat.
    Märki F; Kamber B; Rink H; Sieber P
    J Endocrinol; 1979 Jun; 81(3):315-23. PubMed ID: 469462
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and biological actions of prosomatostatin.
    Meyers CA; Murphy WA; Redding TW; Coy DH; Schally AV
    Proc Natl Acad Sci U S A; 1980 Oct; 77(10):6171-4. PubMed ID: 6108563
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis of a nonreducible cyclic analog of somatostatin having only growth hormone release inhibiting activity.
    Garsky VM; Clark DE; Grant NH
    Biochem Biophys Res Commun; 1976 Dec; 73(4):911-6. PubMed ID: 15625860
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potent, highly selective inhibition of growth hormone secretion by position 4 somatostatin analogs.
    Murphy WA; Meyers CA; Coy DH
    Endocrinology; 1981 Aug; 109(2):491-5. PubMed ID: 6113951
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.